The impact of adenovirus infection on the immunocompromised host

Reviews in Medical Virology

Volumn 13, Issue 3, 2003, Pages 155-171

  Kojaoghlanian, Tsoline ^a   Flomenberg, Phyllis ^b   Horwitz, Marshall S ^a,c  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; RIBAVIRIN; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS; ADULT; AEROSOL; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COLITIS; DIAGNOSTIC TEST; DIARRHEA; DNA DNA HYBRIDIZATION; HEART LUNG TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; ORGAN TRANSPLANTATION; PERSISTENT VIRUS INFECTION; PNEUMONIA; POLYMERASE CHAIN REACTION; REVIEW; SIDE EFFECT; VIRUS DETECTION; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADENOVIRUS INFECTIONS, HUMAN; ANTIBODY FORMATION; ANTIGENS, VIRAL; HEART TRANSPLANTATION; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION;

EID: 0038029587     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.386     Document Type: Review

References (119)

1. Wigger HJ, Blanc WA. Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia. N Engl J Med 1966; 275: 870-874.
2. Myerowitz RL, Stalder H, Oxman MN, et al. Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med 1975; 59: 591-598.
3. Zahradnik JM, Spencer MJ, Porter DD. Adenovirus infection in the immunocompromised patient. Am J Med 1980; 68: 725-732.
4. Shirali GS, Ni J, Chinnock RE, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001; 344: 1498-1503.
5. Rowe WP, Huebner RJ, Gillmore LK, Parrott RH, Ward TG. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1953; 84: 570-573.
6. Huebner RJ, Rowe WP, Ward TG, Parrott RH, Bell JA. Adenoidal-pharyngoconjunctival agents. N Engl J Med 1954; 251: 1077-1086.
7. Brandt CD, Kim HW, Vargosdo AJ. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am J Epidemiol 1969; 90: 484-500.
8. Bennett FM, Law BB, Hamilton W, MacDonald A. Adenovirus eye infections in Aberdeen. Lancet 1957; 12: 670-673.
9. Dawson CR, O'Day D, Vastine D. Adenovirus 19, a cause of epidemic keratoconjunctivitis, not acute hemorrhagic conjunctivitis. N Engl J Med 1975; 293: 45-46.
10. Numazaki Y, Kumasaka T, Yano N, et al. Further study of acute hemorrhagic cystitis due to adenovirus type 11. N Engl J Med 1973; 289: 344-347.
11. Nemunaitis J, Cunningham C, Buchanan A, et al. Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Ther 2001; 8: 746-759.
12. Tio RA, Isner JM, Walsh K. Gene therapy to prevent restenosis, the Boston experience. Semin Interv Cardiol 1998; 3: 205-210.
13. Batshaw ML, Wilson JM, Raper S, Yudkoff M, Robinson MB. Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD). Hum Gene Ther 1999; 10: 2419-2437.
14. Fox JP, Brandt CD, Wassermann FE, et al. The Virus Watch Program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infection and relation to illness. Am J Epidemiol 1969; 89: 25-50.
15. Neumann R, Genersch E, Eggers HJ. Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res 1987; 7: 93-97.
16. Stewart PL, Fuller SD, Burnett RM. 1993. Difference imaging of adenovirus: bridging the resolution gap between x-ray crystallography and electron microscopy. EMBO J 1993; 12: 2589-2599.
17. Friefeld BR, Lichy J, Field J, et al. The in vitro replication of adenovirus DNA in the molecular biology of adenoviruses. In Current Topics in Microbiology and Immunology, Doerfler W (ed.). Springer Verlag: Berlin, 1984; 221-255.
18. Bergelson JM, Cunningham JA, Kurt-Jones E, et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
19. Carson SD. Receptor for the group B coxsackieviruses and adenoviruses: CAR. Rev Med Virol 2001; 11: 219-226.
20. Roelvink PW, Lizonova A, Lee JGM, et al. 1998. The Coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998; 72: 7909-7915.
21. Tomko RP, Johansson CB, Totrov M, Abagyan R, Frisen J, Philipson L. Expression of the adenovirus receptor and its interaction with the fiber knob. Exp Cell Res 2000; 255: 47-55.
22. Song CZ, Loewenstein PM, Green M. Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat. J Virol 1995; 69: 2907-2911.
23. Koopmann J, Dombrowski F, Rockstroh JK, Pfeifer U, Sauerbruch T, Spengler U. Fatal pneumonia in an AIDS patient coinfected with adenovirus and Pneumocystis carinii. Infection 2000; 28: 323-325.
24. Horwitz MS. Adenoviruses. In Fields Virology, Knipe DM, Howley PM (eds). Lippincott-Williams & Wilkins, Philadelphia, USA: 2001; 2301-2326.
25. Wadell G, Allard A, Hierholzer JC. Adenoviruses. In Manual of Clinical Microbiology, Murray P, Baron E (eds). ASM Press: Washington, DC, 1999; 970-982.
26. Ginsberg HS, Moldawer LL, Sehgal PB, et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991; 88: 1651-1655.
27. Mistchenko AS, Diez RA, Mariani AL, et al. Cytokines in adenoviral disease in children: Association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr 1994; 124: 714-719.
28. Pirofski L, Horwitz MS. Adenovirus, infection and immunity. In Encyclopedia of Immunology, Roitt IV, Delves PS (eds). Academic Press: London, UK. 1998; 2: 1514-1516.
29. Smith CA, Woodruff LS, Rooney C, Kitchingman GR. Extensive cross-reactivity of adenovirus specific cytotoxic T cells. Hum Gene Ther 1998; 9: 1419-1427.
30. Olive M, Eisenlohr L, Flomenberg N, Hsu S, Flomenberg P. 2002. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther 2002; 13: 1167-1178.
31. Horwitz MS. 2001. Adenovirus immunoregulatory genes and their cellular targets. Virology 2001; 279: 1-8.
32. Wold WS, Doronin K, Toth K, Kuppuswamy M, Lichtenstein DL, Tollefson AE. Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Curr Opin Immunol 1999; 11: 380-386.
33. Bennett EM, Bennink JR, Yewdell JW, Brodsky FM. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J Immunol 1999; 162: 5049-5052.
34. Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, et al. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 1989; 86: 3823-3827.
35. Mahr JA, Gooding LR. Immune evasion by adenoviruses. Immunol Rev 1999; 168: 121-130.
36. Friedman JM, Horwitz MS. Inhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex. J Virol 2002; 76: 5515-5521.
37. Lesokhin AM, Delgado-Lopez F, Horwitz MS. Inhibition of chemokine expression by adenovirus early region three (e3) genes. J Virol 2002; 76: 8236-8243.
38. Grunhaus A, Cho S, Horwitz MS. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model. Virology 1994; 200: 535-546.
39. Abken H, Butzler C, Willecke K. Adenovirus type 5 persisting in human lymphocytes is unlikely to be involved in immortalization of lymphoid cells by fusion with cytoplasts or by transfection with DNA of mouse L cells. Anticancer Res 1987; 7: 553-558.
40. Flomenberg P, Piaskowski V, Harb J, Segura A, Casper JT. Spontaneous, persistent infection of a B-cell lymphoma with adenovirus. J Med Virol 1987; 48: 267-272.
41. Chu Y, Sperber K, Mayer L, Hsu MT. Persistent infection of human adenovirus type 5 in human monocyte cell lines. Virology 1992; 188: 793-800.
42. Horvath J, Palkonyay L, Weber J. Group C adenovirus DNA sequences in human lymphoid cell. J Virol 1986; 59: 189-192.
43. Lavery DJ, Fu SM, Lufkin T, Chen-Kiang S. Productive infection by cultured human lymphoid cells by adenovirus. J Virol 1987; 61: 1466-1472.
44. Flomenberg P, Gutierrez E, Piaskowski V, Casper JT. Detection of adenovirus DNA in peripheral blood mononuclear cells by polymerase chain reaction. J Med Virol 1997; 51: 182-188.
45. Howard DS, Phillips II GL, Reece DE, et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 1999; 29: 1494-1501.
46. Parizhskaya M, Walpusk J, Mazariegos G, Jaffe R. Enteric adenovirus infection in pediatric small bowel transplant recipients. Pediatr Dev Pathol 2001; 4: 122-128.
47. Ambinder RF, Burns W, Forman M, et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 1986; 146: 1400-1401.
48. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169: 775-781.
49. Wasserman R, August CS, Plotkin SA. Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 1988; 7: 109-115.
50. Foster CB, Choi EH, Chanock SJ. Adenovirus and Marrow Transplantation in Children. Pediatric Pathology and Molecular Medicine. Taylor & Francis: 2000; 97-114.
51. La Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871-876.
52. Hale GA, Heslop HE, Krance RA, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999; 23: 277-282.
53. Baldwin A, Kingman H, Darville M, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1333-1338.
54. Hoffman JA, Shah AJ, Ross A, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 388-394.
55. Echavarria M, Forman M, van Tol MJ, Vossen JM, Charache P, Kroes AC. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 2001; 358: 384-385.
56. Munoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 1998; 27: 1194-1200.
57. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985; 312: 529-533.
58. Purtilo DT, White R, Filipovich A, Kersey J, Zelkowitz L. Fulminant liver failure induced by adenovirus after bone marrow transplantation. N Engl J Med 1985; 312: 1707-1708.
59. Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32: 1325-1330.
60. Boubenider S, Hiesse C, Marchand S, Hafi A, Kriaa F, Charpentier B. Post-transplantation polyomavirus infections. J Nephrol 1999; 12: 24-29.
61. Niemann TH, Trigg ME, Winick N, Penick GD. Disseminated adenoviral infection presenting as acute pancreatitis. Human Pathol 1993; 24: 1145-1148.
62. Fassas AB, Buddharaju LN, Rapoport A, et al. Fatal disseminated adenoviral infection associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation. Leuk Lymphoma 2001; 42: 801-804.
63. Runde V, Ross S, Trenschel R, et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28: 51-57.
64. Lecatsas G, van Wyk JA. DNA viruses in urine after renal transplantation. S Afr Med J 1978; 53: 787-788.
65. Yagisawa T, Nakada T, Takahashi K, Toma H, Ota K, Yaguchi H. Acute hemorrhagic cystitis caused by adenovirus after kidney transplantation. Urol Int 1995; 54: 142-146.
66. Koneru B, Jaffe R, Esquivel CO, Todo S, Iwatsuki S, Starzl TE. Adenoviral infections in pediatric liver transplant recipients. J Am Med Assoc 1987; 258: 489-492.
67. Cames B, Rahier J, Burtomboy G, et al. Acute adenovirus hepatitis in liver transplant recipients. J Pediatr 1992; 120: 33-37.
68. Michaels MG, Green M, Wald ER, Starzl TE. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992; 165: 170-174.
69. McGrath D, Falagas ME, Freeman R, et al. Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance. J Infect Dis 1998; 177: 459-462.
70. Koneru B, Atchison R, Jaffe R, Cassavilla A, Van Thiel DH, Starzl TE. Serological studies of adenoviral hepatitis following pediatric liver transplantation. Transplant Proc 1990; 22: 1547-1548.
71. Schowengerdt KO, Ni J, Denfield SW, et al. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. J Heart Lung Transplant 1996; 15: 111-123.
72. Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 1998; 116: 617-623.
73. Ohori NP, Michaels MG, Jaffe R, Williams P, Yousem SA. Adenovirus pneumonia in lung transplant recipients. Hum Pathol 1995; 26: 1073-1079.
74. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW, et al. 1999. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol 1999; 37: 3940-3945.
75. DeJong PJ, Valderrama G, Spigland I, Horwitz MS. Adenovirus isolates from the urines of patients with the acquired immunodeficiency syndrome. Lancet 1983; 1: 1293-1296.
76. Valderrama-Leon G, Flomenberg P, Horwitz MS. Restriction endonuclease mapping of adenovirus 35, a type isolated from immuncompromised hosts. J Virol 1985; 56: 647-650.
77. Horwitz MS, Valderrama G, Korn R, Spigland I. Adenovirus isolates from the urines of AIDS patients: characterization of group B recombinants. In Acquired Immune Deficiency Syndrome, in UCLA Symposia on Molecular and Cell Biology, New Sereies. Gottlieb MS, Groopman JE (eds). Liss AR, New York: 1984; 16: 187-207.
78. Flomenberg PR, Chen P, Munk G, Horwitz MS. The molecular epidemiology of adenovirus type 35 isolates from immunocompromised hosts. J Infect Dis 1987; 155: 1127-1134.
79. Khoo SH, Bailey AS, De Jong JC, Mandal BK. Adenovirus infections in human immunodeficiency virus-positive patients: clinical features and molecular epidemiology. J Infect Dis 1995; 172: 629-637.
80. Lord A, Bailey AS, Klapper PE, Snowden N, Khoo SH. Impaired humoral responses to subgenus D adenovirusenovirus infections in HIV-positive patients. J Med Virol 2000; 62: 405-409.
81. Crawford-Miksza L, Schnurr DP. Seroepidemiology of new AIDS-associated adenoviruses among the San Francisco Men's Health Study. J Med Virol 1996; 50: 230-236.
82. Durepaire N, Ranger-Rogez S, Gandji JA, Weinbreck P, Rogez JP, Denis F. Enteric prevalence of adenovirus in human immunodeficiency virus seropositive patients. J Med Virol 1995; 45: 56-60.
83. Cunningham AL, Grohman GS, Harkness J, et al. Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus. J Infect Dis 1988; 158: 386-391.
84. Yan Z, Nguyen S, Poles M, Melamed J, Scholes JV. Adenovirus colitis in human immunodeficiency virus infection: an underdiagnosed entity. Am J Surg Pathol 1998; 22: 1101-1106.
85. Orenstein JM, Dieterich DT. The histopathology of 103 consecutive colonoscopy biopsies from 82 symptomatic patients with acquired immunodeficiency syndrome: original and look-back diagnoses. Arch Pathol Lab Med 2001; 125: 1042-1046.
86. Thomas PD, Pollok RC, Gazzard BG. Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. HIV Med 1999; 1: 19-24.
87. Janoff EN, Orenstein JM, Manischewitz JF, Smith PD. Adenovirus colitis in the acquired immunodeficiency syndrome. Gastroenterology 1991; 100: 976-979.
88. Krilov LR, Rubin LG, Frogel M, et al. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev Infect Dis 1990; 12: 303-307.
89. Hierholzer JC. Adenoviruses. In Diagnostic Procedures for Viral Rickettsial and Chlamydial Infections, Lennette EH, Lennette DA, Lennette ET (eds). American Public Health Association: Washington, DC, 1995; 169-188.
90. Shinozaki T, Araki K, Ushijima H, Fujii R, Eshita Y. Use of Graham 293 cells in suspension for isolating enteric adenoviruses form the stools of patients with acute gastroenteritis. J Infect Dis 1987; 156: 246.
91. Grandien M, Pettersson CA, Gardner PS, Linde A, Stanton A. Rapid viral diagnosis of acute respiratory infections: comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions. J Clin Microbiol 1985; 22: 757-760.
92. Allard A, Albinsson B, Wadell G. Detection of adenoviruses in stools from healthy persons and patients with diarrhea by two-step polymerase chain reaction. J Med Virol 1995; 37: 149-157.
93. Kidd AH, Jonsson M, Garwicz D, et al. Rapid subgenus identification of human adenovirus isolates by a general PCR. J Clin Microbiol 1996; 34: 622-627.
94. Echavarria M, Forman M, Ticehurst J, Dumler JS, Charache P. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol 1998; 36: 3323-3326.
95. Pring-Akerblom P, Adrian T. Type- and group-specific polymerase chain reaction for adenovirus detection. Res Virol 1994; 145: 25-35.
96. Pring-Akerblom P, Adrian T, Kostler T. PCR-based detection and typing of human adenoviruses in clinical samples. Res Virol 1997; 148: 225-231.
97. Pring-Akerblom P, Trijssenaar FE, Adrian T, Hoyer H. Multiplex polymerase chain reaction for subgenus-specific detection of human adenoviruses in clinical samples. J Med Virol 1999; 58: 87-92.
98. Xu W, McDonough MC, Erdman DD. Species specific identification of human adenoviruses by a multiplex PCR assay. J Clin Microbiol 2000; 38: 4114-4120.
99. Xu W, Erdman DD. Type-specific identification of human adenovirus 3, 7, and 21 by a multiplex PCR assay. J Med Virol 2001; 64: 537-542.
100. Lankester AC, van Tol MJ, Claas EC, Vossen JM, Kroes AC. Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clin Infect Dis 2002; 34: 864-867.
101. Turner PC, Bailey AS, Cooper RJ, Morris DJ. The polymerase chain reaction for detecting adenovirus DNA in formalin-fixed, paraffin-embedded tissue obtained post mortem. J Infect 1993; 27: 43-46.
102. Liles WC, Cushing H, Holt S, Bryan C, Hackman RC. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant 1993; 12: 409-412.
103. Maslo C, Girard PM, Urban T, Guessant S, Rozenbaum W. Ribavirin therapy for adenovirus pneumonia in an AIDS patient. Am J Respir Crit Care Med 1997; 156: 1263-1264.
104. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001; 32: 1290-1297.
105. Murphy GF, Wood Jr DP, McRoberts JW, Henslee-Downey PJ. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 1993; 149: 565-566.
106. Mann D, Moreb J, Smith S, Gian V. Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report. J Infect 1998; 36: 227-228.
107. Chakrabarti S, Collingham KE, Fegan CD, Milligan DW. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant 1999; 23: 1209-1211.
108. Baba M, Mori S, Shigeta S, DeClerco E. Selective inhibitory effect of (S)-9-3-(3-hydroxy-2-phosphonylmethozyrpopyl)adenine and 2′-nor-cyclic GMP on adenovirus replication in vitro. Antimicrob Agents 1987; 31: 337-339.
109. Gordon YJ, Romanowski E, Araullo-Cruz T, et al. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Res 1991; 16: 11-16.
110. De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 2001; 11: 381-395.
111. Gordon YJ, Romanowski E, Araullo-Cruz T, De Clercq E. Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in hibits adenovirus type 5 replication in the New Zealand rabbit ocular model. Cornea 1992; 11: 529-533.
112. de Oliveira CB, Stevenson D, LaBree L, McDonnell PJ, Trousdale MD. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res 1996; 31: 165-172.
113. Legrand F, Berrebi D, Houhou N, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001; 27: 621-626.
114. Ribaud P, Scieux C, Freymuth F, Morinet F, Gluckman E. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis 1999; 28: 690-691.
115. Chakrabarti S, Collingham KE, Fegan CD, Pillay D, Milligan DW. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant 2000; 26: 305-307.
116. Hromas R, Cornetta K, Srour E, Blanke C, Broun ER. Donor leukocyte infusion as therapy of life threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 1994; 84: 1689-1690.
117. Flomenberg P, Piaskowski V, Truitt RL, Casper JT. Characterization of human proliferative T cell responses to adenovirus [see comments]. J Infect Dis 1995; 171: 1090-1096.
118. Regn S, Raffegerst S, Chen X, Schendel D, Kolb HJ, Roskrow M. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant. Bone Marrow Transplant 2001; 27: 53-64.
119. Shenk T. Adenoviridae. In Fields Virology, Knipe DM, Howley PM (eds). Lippincott-Williams & Wilkins, Philadelphia, USA. 2001; 2265-228.